BR9916963A - Bupropiona para tratamento de doenças virais - Google Patents
Bupropiona para tratamento de doenças viraisInfo
- Publication number
- BR9916963A BR9916963A BR9916963-0A BR9916963A BR9916963A BR 9916963 A BR9916963 A BR 9916963A BR 9916963 A BR9916963 A BR 9916963A BR 9916963 A BR9916963 A BR 9916963A
- Authority
- BR
- Brazil
- Prior art keywords
- bupropion
- treatment
- viral diseases
- virus
- bupropiona
- Prior art date
Links
- SNPPWIUOZRMYNY-UHFFFAOYSA-N bupropion Chemical compound CC(C)(C)NC(C)C(=O)C1=CC=CC(Cl)=C1 SNPPWIUOZRMYNY-UHFFFAOYSA-N 0.000 title abstract 3
- 229960001058 bupropion Drugs 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 230000003612 virological effect Effects 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 abstract 2
- 241000700588 Human alphaherpesvirus 1 Species 0.000 abstract 1
- 241000701074 Human alphaherpesvirus 2 Species 0.000 abstract 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13549498P | 1998-12-08 | 1998-12-08 | |
| PCT/AU1999/001089 WO2000033827A1 (en) | 1998-12-08 | 1999-12-07 | Bupropion to treat viral diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9916963A true BR9916963A (pt) | 2002-03-05 |
Family
ID=22468359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9916963-0A BR9916963A (pt) | 1998-12-08 | 1999-12-07 | Bupropiona para tratamento de doenças virais |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US6512011B1 (https=) |
| EP (1) | EP1156791B1 (https=) |
| JP (1) | JP4166955B2 (https=) |
| AT (1) | ATE295159T1 (https=) |
| AU (1) | AU762624B2 (https=) |
| BR (1) | BR9916963A (https=) |
| CA (1) | CA2349487C (https=) |
| DE (1) | DE69925312T2 (https=) |
| ES (1) | ES2242438T3 (https=) |
| HK (1) | HK1042239B (https=) |
| MX (1) | MXPA01005725A (https=) |
| NZ (1) | NZ512716A (https=) |
| PT (1) | PT1156791E (https=) |
| WO (1) | WO2000033827A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030134905A1 (en) * | 2002-01-11 | 2003-07-17 | Reindler Christopher William | Bupropion to treat viral diseases |
| DE102004063132A1 (de) * | 2004-12-22 | 2006-07-06 | Schmiegel, Wolff, Prof. Dr. | Verwendung von Bupropion in Arzneimittel zur Behandlung von Hepatitis C |
| CN101534808A (zh) * | 2005-06-27 | 2009-09-16 | 拜维尔实验室国际有限公司 | 丁氨苯丙酮盐的改良释放配制品 |
| GB2477584A (en) * | 2010-02-04 | 2011-08-10 | Biocopea Ltd | A compound for use in treating an acute viral infection |
| WO2011018653A2 (en) * | 2009-08-10 | 2011-02-17 | Biocopea Limited | Treatment of viral infections |
| CN108721262A (zh) * | 2017-04-13 | 2018-11-02 | 中国科学院武汉病毒研究所 | 安非他酮在制备治疗或预防流感病毒感染的药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4438138A (en) * | 1982-12-06 | 1984-03-20 | Burroughs Wellcome Co. | Reduction of cholesterol with meta-chloro α-t-butylaminopropiophenone |
| US4507323A (en) * | 1984-07-25 | 1985-03-26 | Burroughs Wellcome Co. | Treatment of psychosexual dysfunctions |
| US5753712A (en) * | 1994-02-18 | 1998-05-19 | Pinsker; Walter | Treatment of migraine headaches and formulations |
| AUPN814496A0 (en) * | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
-
1999
- 1999-12-07 JP JP2000586320A patent/JP4166955B2/ja not_active Expired - Fee Related
- 1999-12-07 EP EP99960723A patent/EP1156791B1/en not_active Expired - Lifetime
- 1999-12-07 BR BR9916963-0A patent/BR9916963A/pt not_active IP Right Cessation
- 1999-12-07 ES ES99960723T patent/ES2242438T3/es not_active Expired - Lifetime
- 1999-12-07 US US09/787,024 patent/US6512011B1/en not_active Expired - Fee Related
- 1999-12-07 PT PT99960723T patent/PT1156791E/pt unknown
- 1999-12-07 WO PCT/AU1999/001089 patent/WO2000033827A1/en not_active Ceased
- 1999-12-07 MX MXPA01005725A patent/MXPA01005725A/es not_active IP Right Cessation
- 1999-12-07 NZ NZ512716A patent/NZ512716A/en unknown
- 1999-12-07 AU AU17629/00A patent/AU762624B2/en not_active Ceased
- 1999-12-07 AT AT99960723T patent/ATE295159T1/de not_active IP Right Cessation
- 1999-12-07 CA CA002349487A patent/CA2349487C/en not_active Expired - Fee Related
- 1999-12-07 DE DE69925312T patent/DE69925312T2/de not_active Expired - Fee Related
- 1999-12-07 HK HK02103897.6A patent/HK1042239B/en not_active IP Right Cessation
-
2002
- 2002-06-25 US US10/178,498 patent/US20020173551A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE69925312D1 (de) | 2005-06-16 |
| ATE295159T1 (de) | 2005-05-15 |
| JP4166955B2 (ja) | 2008-10-15 |
| DE69925312T2 (de) | 2006-03-09 |
| HK1042239B (en) | 2005-12-09 |
| EP1156791A1 (en) | 2001-11-28 |
| PT1156791E (pt) | 2005-08-31 |
| US6512011B1 (en) | 2003-01-28 |
| EP1156791B1 (en) | 2005-05-11 |
| US20020173551A1 (en) | 2002-11-21 |
| JP2002531495A (ja) | 2002-09-24 |
| CA2349487C (en) | 2007-09-11 |
| WO2000033827A1 (en) | 2000-06-15 |
| CA2349487A1 (en) | 2000-06-15 |
| ES2242438T3 (es) | 2005-11-01 |
| MXPA01005725A (es) | 2003-07-14 |
| EP1156791A4 (en) | 2002-05-02 |
| AU1762900A (en) | 2000-06-26 |
| HK1042239A1 (en) | 2002-08-09 |
| AU762624B2 (en) | 2003-07-03 |
| NZ512716A (en) | 2003-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY117892A (en) | Therapeutic compounds | |
| PT668763E (pt) | Utilizacao de fenserina para a preparacao de medicamentos para tratar doencas do conhecimento | |
| EP0509317A3 (en) | Use of droloxifene in the treatment of bone diseases | |
| EP1064000A4 (en) | VITAMIN D AND ITS ANALOGS FOR THE TREATMENT OF TUMORS AND OTHER HYPERPROLIFERATION DISORDERS | |
| BR0010531A (pt) | Composições e usos de et743 para tratamento de câncer | |
| ES2160643T3 (es) | Composiciones que contienen g-csf y proteina de union al tnf. | |
| DK0501705T3 (da) | Anvendelse af tomoxetin til behandling af sygdomme i de nedre urinveje | |
| ES2136167T3 (es) | Composiciones de idebenona para tratar la enfermedad de alzheimer. | |
| DE60018409D1 (de) | Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren | |
| ZA991749B (en) | Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy. | |
| MX9805441A (es) | Compuestos terapeuticos. | |
| BR9916963A (pt) | Bupropiona para tratamento de doenças virais | |
| BRPI0409699A (pt) | métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos | |
| HUP0202525A2 (hu) | Mofetil mikofenolát és PEG-IFN-alfa együttes alkalmazása, valamint az azokat tartalmazó gyógyszerkészítmények és kit | |
| GR3032224T3 (en) | Therapeutic agent for threatened abortion. | |
| WO2000016786A3 (en) | Oxihumic acid and its use in the treatment of various conditions | |
| BR0212249A (pt) | Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto | |
| DE3872881D1 (de) | Arzneimittelzusammensetzung zur vorbeugung und behandlung bakterieller und viraler krankheiten. | |
| KR900007434A (ko) | 시스타틴을 유효 성분으로하는 치료제 | |
| WO1997026880A3 (en) | Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients | |
| Naik et al. | 8-Methoxypsoralen-lnduced Nail Pigmentation. | |
| BR0114339A (pt) | Composições farmaceuticamente aceitáveis contendo epinastina e pseudoefedrina | |
| LV11524A (lv) | Benzidamina izmantosana TNF izsaukto patologisko stavoklu arstesana | |
| MY112888A (en) | Use of bradykinin antagonists for the preparation of medicaments for the treatment of virus diseases. | |
| HU9201295D0 (en) | Medical preparations for treating cryptosporidiosys |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B15I | Others concerning applications: loss of priority |
Free format text: PERDA DA PRIORIDADE REIVINDICADA POR NAO ATENDER A DISPOSICAO PREVISTA NO ART. 16 6O DA LPI. |
|
| B12F | Other appeals [chapter 12.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 11A E 12A ANUIDADE |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012. |